Rein Therapeutics, Inc. financial data

Symbol
RNTX on Nasdaq
Location
Austin, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 134% % -64%
Debt-to-equity 16% % 92%
Return On Equity -119% % -292%
Return On Assets -102% % -265%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26,286,382 shares 21%
Common Stock, Shares, Outstanding 25,140,092 shares 16%
Common Stock, Value, Issued $111,000 USD 2.8%
Weighted Average Number of Shares Outstanding, Basic 26,361,386 shares 22%
Weighted Average Number of Shares Outstanding, Diluted 26,361,386 shares 22%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $0 USD
Research and Development Expense $12,349,000 USD -4.3%
General and Administrative Expense $11,420,000 USD -32%
Operating Income (Loss) $60,769,000 USD -105%
Net Income (Loss) Attributable to Parent $58,885,000 USD -101%
Earnings Per Share, Basic -2 USD/shares 16%
Earnings Per Share, Diluted -2 USD/shares 16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,048,000 USD -77%
Other Assets, Current $997,000 USD 32%
Assets, Current $5,174,000 USD -72%
Property, Plant and Equipment, Net $0 USD -100%
Intangible Assets, Net (Excluding Goodwill) $42,200,000 USD -47%
Goodwill $6,330,000 USD 0%
Other Assets, Noncurrent $2,000 USD 0%
Assets $53,706,000 USD -48%
Accounts Payable, Current $4,123,000 USD 282%
Employee-related Liabilities, Current $710,000 USD -51%
Liabilities, Current $5,744,000 USD 1.5%
Deferred Income Tax Liabilities, Net $1,772,000 USD -47%
Other Liabilities, Noncurrent $0 USD
Liabilities $7,516,000 USD -16%
Accumulated Other Comprehensive Income (Loss), Net of Tax $44,000 USD -69%
Retained Earnings (Accumulated Deficit) $369,304,000 USD -19%
Stockholders' Equity Attributable to Parent $46,190,000 USD -51%
Liabilities and Equity $53,706,000 USD -48%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 25,140,092 shares 16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $58,903,000 USD -101%
Share-based Payment Arrangement, Expense $2,100,000 USD 67%